Kingfisher plc

Kingfisher plc Transformation activity continued in H1

Kingfisher plc (LON:KGF) has today announced its half year results for the 6 months ended 31 July 2019. H1 19/20 Group results: ·    Total sales down 0.9% in constant currency ·    LFL down 1.8% with growth in Screwfix, Poland and Romania offset by B&Q and France ·    Transformation activity continued across the Group including significant new range implementation in H1 o  Unified product (COGS) now …

British Land company plc

British Land Company Operational Update & Investor Day

Investor Day British Land Company PLC (LON:BLND) is today hosting an event for institutional investors and analysts at Storey Club, Paddington Central. The event will include presentations from senior management and updates from across the business. Presentation materials will be made available on our website britishland.com/investors from noon on 18 September 2019.   The event will not be webcast live, …

AstraZeneca new agreement gives them full responsibility for Linzess in China

AstraZeneca plc (LON:AZN) has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess* (linaclotide), a first-in-class new treatment for patients with irritable bowel syndrome with constipation (IBS-C). IBS-C is characterised by symptoms of abdominal pain and constipation, is a chronic and prevalent functional gastrointestinal disorder in China and there are currently few treatment …

BHP Group PLC

BHP Group announce 2020 Interim Dividend dates

The proposed dates(1) for the 2020 Interim Dividend of BHP Group Limited and BHP Group PLC (LON:BHP) are set out below. BHP’s Dividend Reinvestment Plan (DRP) will operate in respect of the 2020 Interim Dividend. Full terms and conditions of the DRP and details about how to participate can be found at bhp.com. 2020 Interim Dividend Half Yearly Results Announcement …

Barratt Developments 2019 Annual Report & Accounts and Notice of AGM

Further to Barratt Developments PLC (LON:BDEV) announcement of its annual results on 4 September 2019, copies of the Company’s Annual Report and Accounts for the financial year ended 30 June 2019 and the Notice of Annual General Meeting of the Company have today been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM. The above …

Direct Line Insurance Group PLC

Direct Line Group appoints new CFO Tim Harris

Direct Line Insurance Group plc (LON: DLG) announced today that Tim Harris will join the Company as Chief Financial Officer and the Board as an Executive Director on 1st October 2019. Tim was Deputy Chief Executive and Group Finance Director of the Royal London Group until 12 July 2019. He joined Royal London as Group Finance Director in May 2014 …

SSE Plc

SSE PLC Agreement to sell SSE Energy Services to OVO Energy

SSE PLC (LON:SSE) have today entered into an agreement to sell its SSE Energy Services business to OVO Energy Limited, a wholly owned subsidiary of OVO Group Limited, at an enterprise value of £500m comprising £400m cash and £100m in loan notes.  Completion of the Transaction is expected in late 2019 or early 2020 and is subject to the necessary …

British American Tobacco plc

British American Tobacco A stronger, simpler and faster organisation

British American Tobacco PLC (LON:BATS) today announced an important step in a programme to simplify its business and create a more efficient, agile and focused BAT. This will ensure the company is better placed to meet ever evolving consumer needs and deliver savings that can be reinvested in the growth of its portfolio of new categories such as vapour, tobacco …

WM Morrison Supermarkets

WM Morrison Supermarkets Maintaining momentum

WM Morrison Supermarkets (LON: MRW) has today provided interim results for the half year to 4th August 2019. Financial summary · Group like-for-like (LFL) sales(1) ex-fuel/ex-VAT up 0.2% (2018/19: 4.9%) · Q2 Group LFL ex-fuel/ex-VAT down 1.9% (Q2 2018/19: up 6.3%) · Total revenue up 0.4% to £8.83bn (2018/19: £8.80bn) · Profit before tax and exceptionals(2) up 5.3% to £198m …

Immupharma plc

Anifrolumab update positive for lupus field – while ImmuPharma’s LupuzorTM could represent a highly successful product

The Life Sciences Division (TLSD), a specialist investment bank to global life sciences companies, today announced an update report on ImmuPharma plc, a pharmaceutical development company listed on AIM of the London Stock Exchange focusing on developing novel medicines with high sales potential in specialist markets with serious unmet need. Summary highlights of the update include: AstraZeneca (LON: AZN) announced …